Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 10/20 | 0.39 |
| ▸ | MMP3 | P08254 | 8/20 | 0.39 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.39 |
| ▸ | ESRRG | P62508 | 1/20 | 0.38 |
| ▸ | MMP1 | P03956 | 6/20 | 0.37 |
| ▸ | MMP9 | P14780 | 3/20 | 0.37 |
| ▸ | MMP14 | P50281 | 3/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.35 |
| ▸ | MMP7 | P09237 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29178419 | 0.89 | MMP2 (0.50) | MMP2MMP3SCN9AMMP1MMP9 | |
| SCHEMBL29178411 | 0.87 | MMP2 (0.43) | MMP2MMP3SCN9AMMP1 | |
| SCHEMBL29178358 | 0.87 | RAB9A (0.41) | MMP2MMP3SCN9AMMP1MMP9 | |
| SCHEMBL29178370 | 0.82 | CALM1 (0.39) | MMP2MMP3SPHK1CALM1 | |
| SCHEMBL29178372 | 0.82 | CALM1 (0.39) | MMP2MMP3SPHK1CALM1 | |
| SCHEMBL29178322 | 0.81 | SCN9A (0.39) | MMP2MMP3SCN9AMMP1MMP9 | |
| SCHEMBL29178466 | 0.81 | CHRNA7 (0.45) | SCN9A | |
| SCHEMBL29178298 | 0.77 | SCN9A (0.35) | SCN9A | |
| SCHEMBL29178425 | 0.77 | SCN9A (0.42) | SCN9ATSHR | |
| SCHEMBL25139698 | 0.73 | CTSK (0.54) | MMP3MMP1MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117561058-A | CDK2 inhibitors and methods of use thereof | 塞迪拉治疗股份有限公司 | 2024-02-13 | — | — | CN | disclosed |